RxDoctor Payments Data

Jill Northover, APRN

Family · Canton, GANPI 1326338609

Payments from drug & device makers

$873in general payments, 2019–2025

Across 41 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$220
  • GSK$215
  • Boehringer Ingelheim$170
  • Nevro Corp.$68
  • Novo Nordisk$50
  • Amgen$36
  • plus $113 from 7 others

What the payments were for

  • Food & beverage$873100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$873 in reported general payments places this provider in the 65th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$27,488
Medicare patients
183
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OfevNintedanib Esylate11$142,962
Trelegy ElliptaFluticasone/Umeclidin/Vilanter143$108,451
Breo ElliptaFluticasone/Vilanterol52$23,946
SymbicortBudesonide/Formoterol Fumarate72$16,579
Fluticasone-SalmeterolFluticasone Propion/Salmeterol91$14,302
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$11,060
Advair HfaFluticasone Propion/Salmeterol22$10,902
Wixela InhubFluticasone Propion/Salmeterol54$9,566
Albuterol Sulfate HfaAlbuterol Sulfate210$6,279
Advair DiskusFluticasone Propion/Salmeterol12$4,043
Fluticasone Propionate130$1,596
Ventolin HfaAlbuterol Sulfate29$1,566
Montelukast Sodium146$1,473
Azelastine Hcl22$965
Azithromycin23$316

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimOfev$170$142,96211 claims
GSKTrelegy Ellipta, Breo Ellipta$215$132,396195 claims
AstraZenecaSymbicort, Breztri Aerosphere$220$27,63987 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,258 family providers in Georgia.

Other family in Canton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →